Similarly, the CTCFL TCR‐T cells efficiently recognized ovarian cancer cell lines treated with DAC, implying that pretreatment with DAC may increase the reactivity of transferred TCR‐T cells in patients.72 This evidence concerns the gene CTCFL and ovarian carcinoma.